485 related articles for article (PubMed ID: 9421295)
41. Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.
Terrón JA; Falcón-Neri A
Br J Pharmacol; 1999 Jun; 127(3):609-16. PubMed ID: 10401550
[TBL] [Abstract][Full Text] [Related]
42. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
Manuel NA; Wallis DI; Crick H
Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
44. 5-HT1-like receptor-mediated contraction in the human internal mammary artery.
Yildiz O; Ciçek S; Ay I; Tatar H; Tuncer M
J Cardiovasc Pharmacol; 1996 Jul; 28(1):6-10. PubMed ID: 8797129
[TBL] [Abstract][Full Text] [Related]
45. 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.
Morecroft I; Heeley RP; Prentice HM; Kirk A; MacLean MR
Br J Pharmacol; 1999 Oct; 128(3):730-4. PubMed ID: 10516655
[TBL] [Abstract][Full Text] [Related]
46. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
[TBL] [Abstract][Full Text] [Related]
47. Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries.
Ishida T; Kawashima S; Hirata Ki ; Sakoda T; Shimokawa Y; Miwa Y; Inoue N; Ueyama T; Shiomi M; Akita H; Yokoyama M
Circulation; 2001 Mar; 103(9):1289-95. PubMed ID: 11238275
[TBL] [Abstract][Full Text] [Related]
48. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
[TBL] [Abstract][Full Text] [Related]
49. Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha1 receptors in isolated arteries of rat and guinea pig.
Schöning C; Flieger M; Pertz HH
J Anim Sci; 2001 Aug; 79(8):2202-9. PubMed ID: 11518230
[TBL] [Abstract][Full Text] [Related]
50. 5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone.
MacLean MR; Clayton RA; Hillis SW; McIntyre PD; Peacock AJ; Templeton AG
Pulm Pharmacol; 1994 Feb; 7(1):65-72. PubMed ID: 7516208
[TBL] [Abstract][Full Text] [Related]
51. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
52. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
53. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
54. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
Keegan A; Morecroft I; Smillie D; Hicks MN; MacLean MR
Circ Res; 2001 Dec; 89(12):1231-9. PubMed ID: 11739290
[TBL] [Abstract][Full Text] [Related]
55. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Jähnichen S; Radtke OA; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
[TBL] [Abstract][Full Text] [Related]
56. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
Hinton JM; Hill P; Jeremy J; Garland C
J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
[TBL] [Abstract][Full Text] [Related]
57. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
Rogines-Velo MP; Pelorosso FG; Zold CL; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
[TBL] [Abstract][Full Text] [Related]
58. Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries.
Chan KY; de Vries R; Leijten FP; Pfannkuche HJ; van den Bogaerdt AJ; Danser AH; MaassenVanDenBrink A
Eur J Pharmacol; 2009 Oct; 619(1-3):61-7. PubMed ID: 19619527
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
60. Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed.
Rodat-Despoix L; Crevel H; Marthan R; Savineau JP; Guibert C
J Vasc Res; 2008; 45(3):181-92. PubMed ID: 18025789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
